Shredy logo
  • Features
  • How it works
Talk to Experts
Shredy logo
  • Features
  • How it works
Talk to Experts

    ← R&D leaderboard

    Eupraxia Pharmaceuticals

    Eupraxia Pharmaceuticals Inc. · EPRX (TSX) · Victoria, BC · Pharmaceuticals

    Latest R&D (CAD)
    $29.8M
    Period ended 2025-12-31
    Revenue (CAD)
    —
    Intensity —
    Filings in database
    4
    Investor relations →

    R&D by fiscal period

    2025
    $29.8M
    2024
    $22.0M
    2023
    $27.5M
    2022
    $17.7M
    Period endR&D (CAD)Revenue (CAD)Native R&DFormSource
    2025-12-31$29,817,389—$21,331,656 USD40-FSEC EDGAR
    2024-12-31$22,025,392—$16,079,276 USD40-FSEC EDGAR
    2023-12-31$27,484,108—$20,363,124 USD40-FSEC EDGAR
    2022-12-31$17,736,529—$13,629,854 USD40-FSEC EDGAR
    shredy logo in black

    Shredy transforms the tedious task of claiming SR&ED into a seamless, fast, and reliable process. Perfect for accounting firms, tech startup founders, and specialized consultancies, this AI-enabled tool is your key to efficient and compliant SR&ED filings.

    Resources

    • FAQ
    • About Us
    • Privacy Policy
    • Terms of Service

    Business Tools

    • Grant & Funding Finder
    • Canada R&D Leaderboard
    • R&D Investment Calculator
    • Startup Valuation
    • Burn Rate Calculator
    • ROI Calculator

    Services by Province

    • Ontario
    • British Columbia
    • Alberta
    • Quebec
    • Saskatchewan
    • Manitoba

    Services by City

    • Toronto, ON
    • Vancouver, BC
    • Calgary, AB
    • Montreal, QC
    • Ottawa, ON
    • Edmonton, AB

    SR&ED Services

    SR&ED FilingInnovation GrantsSR&ED Eligibility Quiz

    Alternatives

    Talk to ExpertsFind a Consultant

    Funding Resources

    Startup FundingResearch Funding

    Website made with ♥ in beautiful Vancouver, British Columbia.